Biotech | May 06, 2022
Procter & Gamble Health posts 14 per cent growth in net profit in Q3
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
This agreement is truly remarkable for achieving greater objectives in the projects and addressing larger problems
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
The research was funded by the National Institutes of Health, the Eversight Center for Vision and Eye Banking Research, and Research to Prevent Blindness
The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.
The approved product has a market size of US $ 1172 million for the twelve months ending March 2022, according to IQVIA
The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months
The inspection report contains no 'critical' observations and only one of the deficiencies is categorized as 'major' which is being addressed expeditiously in consultation with the regulatory agency
Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma
Subscribe To Our Newsletter & Stay Updated
